A new model for providing cell-free DNA and risk assessment for chromosome abnormalities in a public hospital setting

Journal of Pregnancy

Volumn 2014, Issue , 2014, Pages

  Wallerstein, Robert ^a   Jelks, Andrea ^a   Garabedian, Matthew J ^a  

^a SANTA CLARA VALLEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AMNIOCENTESIS; ARTICLE; BLOOD; CELL FREE SYSTEM; CHORION VILLUS SAMPLING; CHROMOSOME 18; CHROMOSOME DISORDER; DOWN SYNDROME; ECHOGRAPHY; FEMALE; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; GENETIC COUNSELING; GENETIC SERVICE; HUMAN; MATERNAL AGE; PATIENT EDUCATION; PATIENT PREFERENCE; PREGNANCY; PROGRAM DEVELOPMENT; PUBLIC HOSPITAL; SECOND TRIMESTER PREGNANCY; TRISOMY; TRISOMY 18; UTILIZATION REVIEW;

ADULT; AMNIOCENTESIS; CELL-FREE SYSTEM; CHORIONIC VILLI SAMPLING; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 18; DNA; DOWN SYNDROME; FEMALE; GENETIC COUNSELING; GENETIC SERVICES; HOSPITALS, PUBLIC; HUMANS; MATERNAL AGE; PATIENT EDUCATION AS TOPIC; PATIENT PREFERENCE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PROGRAM DEVELOPMENT; TRISOMY; ULTRASONOGRAPHY, PRENATAL;

EID: 84904647858     PISSN: 20902727     EISSN: 20902735     Source Type: Journal    
DOI: 10.1155/2014/962720     Document Type: Article

References (32)

1. Chiu R. W. K., Akolekar R., Zheng Y. W. L., Leung T. Y., Sun H., Chan K. C. A., Lun F. M. F., Go A. T. J. I., Lau E. T., To W. W. K., Leung W. C., Tang R. Y. K., Au-Yeung S. K. C., Lam H., Kung Y. Y., Zhang X., Van Vugt J. M. G., Minekawa R., Tang M. H. Y., Wang J., Oudejans C. B. M., Lau T. K., Nicolaides K. H., Lo Y. M. D., Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. British Medical Journal 2011 342 7790 c7401 10.1136/bmj.c7401 2-s2.0-78751683468
2. Ehrich M., Deciu C., Zwiefelhofer T., Tynan J. A., Cagasan L., Tim R., Lu V., McCullough R., McCarthy E., Nygren A. O. H., Dean J., Tang L., Hutchison D., Lu T., Wang H., Angkachatchai V., Oeth P., Cantor C. R., Bombard A., van den Boom D., Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. American Journal of Obstetrics and Gynecology 2011 204 3 205 e11 10.1016/j.ajog.2010.12.060 2-s2.0-79952302397
3. Sparks A. B., Wang E. T., Struble C. A., Barrett W., Stokowski R., Mcbride C., Zahn J., Lee K., Shen N., Doshi J., Sun M., Garrison J., Sandler J., Hollemon D., Pattee P., Tomita-Mitchell A., Mitchell M., Stuelpnagel J., Song K., Oliphant A., Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenatal Diagnosis 2012 32 1 3 9 10.1002/pd.2922 2-s2.0-84857502701
4. Palomaki G. E., Deciu C., Kloza E. M., Lambert-Messerlian G. M., Haddow J. E., Neveux L. M., Ehrich M., Van Den Boom D., Bombard A. T., Grody W. W., Nelson S. F., Canick J. A., DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as down syndrome: an international collaborative study. Genetics in Medicine 2012 14 3 296 305 10.1038/gim.2011.73 2-s2.0-84857868297
5. Palomaki G. E., Kloza E. M., Lambert-Messerlian G. M., Haddow J. E., Neveux L. M., Ehrich M., Van Den Boom D., Bombard A. T., Deciu C., Grody W. W., Nelson S. F., Canick J. A., DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genetics in Medicine 2011 13 11 913 920 10.1097/GIM.0b013e3182368a0e 2-s2.0-80755172331
6. Chen E. Z., Chiu R. W. K., Sun H., Akolekar R., Chan K. C. A., Leung T. Y., Jiang P., Zheng Y. W. L., Lun F. M. F., Chan L. Y. S., Jin Y., Go A. T. J. I., Lau E. T., To W. W. K., Leung W. C., Tang R. Y. K., Au-Yeung S. K. C., Lam H., Kung Y. Y., Zhang X., van Vugt J. M. G., Minekawa R., Tang M. H. Y., Wang J., Oudejans C. B. M., Lau T. K., Nicolaides K. H., Lo Y. M. D., Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma dna sequencing. PLoS ONE 2011 6 7 e21791 10.1371/journal.pone.0021791 2-s2.0-79959937504
7. Bianchi D. W., Platt L. D., Goldberg J. D., Abuhamad A. Z., Sehnert A. J., Rava R. P., Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstetrics and Gynecology 2012 119 890 901 2-s2.0-84866941628
8. Norton M. E., Brar H., Weiss J., Karimi A., Laurent L. C., Caughey A. B., Rodriguez M. H., Williams J. III, Mitchell M. E., Adair C. D., Lee H., Jacobsson B., Tomlinson M. W., Oepkes D., Hollemon D., Sparks A. B., Oliphant A., Song K., Non-invasive chromosomal evaluation (NICE) study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. The American Journal of Obstetrics and Gynecology 2012 207 2 137-e1 137-e8 10.1016/j.ajog.2012.05.021 2-s2.0-84864408781
9. American College of Obstetricians and Gynecologists Committee on Genetics, Committee opinion no. 545: noninvasive prenatal testing for fetal aneuploidy. Obstetrics and Gynecology 2012 120 6 1532 1534 10.1097/01.AOG. 0000423819.85283.f4
10. Bethune M., Literature review and suggested protocol for managing ultrasound soft markers for Down syndrome: thickened nuchal fold, echogenic bowel, shortened femur, shortened humerus, pyelectasis and absent or hypoplastic nasal bone. Australasian Radiology 2007 51 3 218 225 10.1111/j.1440-1673.2007. 01713.x 2-s2.0-34248332529 (Pubitemid 46743846)
11. Bethune M., Management options for echogenic intracardiac focus and choroid plexus cysts: a review including Australian Association of Obstetrical and Gynaecological Ultrasonologists consensus statement. Australasian Radiology 2007 51 4 324 329 10.1111/j.1440-1673.2007.01716.x 2-s2.0-34447304620 (Pubitemid 47052683)
12. Vintzileos A. M., Egan J. F. X., Smulian J. C., Campbell W. A., Guzman E. R., Rodis J. F., Adjusting the risk for trisomy 21 by a simple ultrasound method using fetal long-bone biometry. Obstetrics and Gynecology 1996 87 6 953 958 10.1016/0029-7844(96)00058-0 2-s2.0-0029904223 (Pubitemid 26159391)
13. Benacerraf B. R., Mandell J., Estroff J. A., Harlow B. L., Frigoletto F. D. Jr., Fetal pyelectasis: a possible association with Down syndrome. Obstetrics and Gynecology 1990 76 1 58 60 2-s2.0-0025285433 (Pubitemid 20205219)
14. Tischler R., Hudgins L., Blumenfeld Y. J., Greely H. T., Ormond K. E., Noninvasive prenatal diagnosis: pregnant women's interest and expected uptake. Prenatal Diagnosis 2011 31 13 1292 1299 10.1002/pd.2888 2-s2.0-82255192286
15. Kooij L., Tymstra T., van Berg P. D., The attitude of women toward current and future possibilities of diagnostic testing in maternal blood using fetal DNA. Prenatal Diagnosis 2009 29 2 164 168 10.1002/pd.2205 2-s2.0-59649113579
16. Taylor J. B., Chock V. Y., Hudgins L., NIPT in a clinical setting: an analysis of uptake in the first months of clinical availability. Journal of Genetic Counseling 2013 23 1 72 78 10.1007/s10897-013-9609-z
17. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstetrics and Gynecology 2007 109 1 217 227
18. Chetty S., Garabedian M. J., Norton M. E., Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening. Prenatal Diagnosis 2013 33 6 542 546 10.1002/pd.4125 2-s2.0-84878125815
19. Aagaard-Tillery K. M., Malone F. D., Nyberg D. A., Porter T. F., Cuckle H. S., Fuchs K., Sullivan L., Comstock C. H., Saade G. R., Eddleman K., Gross S., Dugoff L., Craigo S. D., Timor-Tritsch I. E., Carr S. R., Wolfe H. M., Bianchi D. W., D'Alton M. E., Role of second-trimester genetic sonography after down syndrome screening. Obstetrics and Gynecology 2009 114 6 1189 1196 10.1097/AOG.0b013e3181c15064 2-s2.0-73349093464
20. Nyberg D. A., Souter V. L., Use of genetic sonography for adjusting the risk for fetal Down syndrome. Seminars in Perinatology 2003 27 2 130 144 10.1053/sper.2003.50012 2-s2.0-0038305570 (Pubitemid 36547480)
21. Norton M. E., Rose N. C., Benn P., Noninvasive prenatal testing for fetal aneuploidy: clinical assessment and a plea for restraint. Obstetrics and Gynecology 2013 121 4 847 850 10.1097/AOG.0b013e31828642c6 2-s2.0-84876270082
22. Malone F. D., Canick J. A., Ball R. H., Nyberg D. A., Comstock C. H., Bukowski R., Berkowitz R. L., Gross S. J., Dugoff L., Craigo S. D., Timor-Tritsch I. E., Carr S. R., Wolfe H. M., Dukes K., Bianchi D. W., Rudnicka A. R., Hackshaw A. K., Lambert-Messerlian G., Wald N. J., D'Alton M. E., First-trimester or second-trimester screening, or both, for down's syndrome. The New England Journal of Medicine 2005 353 19 2001 2011 10.1056/NEJMoa043693 2-s2.0-27744477773 (Pubitemid 41609093)
23. Benn P., Cuckle H., Pergament E., Non-invasive prenatal testing for aneuploidy: current status and future prospects. Ultrasound in Obstetrics and Gynecology 2013 42 1 15 33 10.1002/uog.12513 2-s2.0-84879487413
24. Mogra R., Alabbad N., Hyett J., Increased nuchal translucency and congenital heart disease. Early Human Development 2012 88 5 261 267 10.1016/j.earlhumdev.2012.02.009 2-s2.0-84859824168
25. Makrydimas G., Sotiriadis A., Huggon I. C., Simpson J., Sharland G., Carvalho J. S., Daubeney P. E., Ioannidis J. P. A., Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centers. American Journal of Obstetrics and Gynecology 2005 192 1 89 95 10.1016/j.ajog.2004.06.081 2-s2.0-12844258350 (Pubitemid 40164225)
26. Westin M., Saltvedt S., Bergman G., Almström H., Grunewald C., Valentin L., Is measurement of nuchal translucency thickness a useful screening tool for heart defects? A study of 16 383 fetuses. Ultrasound in Obstetrics & Gynecology 2006 27 6 632 639 10.1002/uog.2792 2-s2.0-33745638323 (Pubitemid 43967365)
27. Jouannic J., Thieulin A., Bonnet D., Houyel L., Lelong N., Goffinet F., Khoshnood B., Measurement of nuchal translucency for prenatal screening of congenital heart defects: a population-based evaluation. Prenatal Diagnosis 2011 31 13 1264 1269 10.1002/pd.2883 2-s2.0-82255179145
28. Simpson L. L., Malone F. D., Saade G. R., D'Alton M. E., Nuchal translucency and the risk of congenital heart disease. Obstetrics and Gynecology 2007 109 6 1456 1457 10.1097/01.AOG.0000267188.20278.b0 2-s2.0-34249901287 (Pubitemid 46869895)
29. Song K., Musci T. J., Caughey A. B., Clinical utility and cost of non-invasive prenatal testing with cfDNA analysis in high-risk women based on a US population. Journal of Maternal-Fetal and Neonatal Medicine 2013 26 12 1180 1185 10.3109/14767058.2013.770464 2-s2.0-84880304596
30. Cuckle H., Benn P., Pergament E., Maternal cfDNA screening for Down syndrome-a cost sensitivity analysis. Prenatal Diagnosis 2013 33 7 636 642 10.1002/pd.4157 2-s2.0-84880042743
31. Wald N. J., Bestwick J. P., Incorporating DNA sequencing into current prenatal screening practice for Down's syndrome. PLoS ONE 2013 8 3 e58732 10.1371/journal.pone.0058732 2-s2.0-84875179556
32. Mersy E., Smits L. J. M., van Winden L. A. A. P., Die-Smulders C. E. M. D., Paulussen A. D. C., Macville M. V. E., Coumans A. B. C., Frints S. G. M., Noninvasive detection of fetal trisomy 21: systematic review and report of quality and outcomes of diagnostic accuracy studies performed between 1997 and 2012. Human Reproduction Update 2013 19 4 318 329 10.1093/humupd/dmt001 2-s2.0-84879440987